NCT06401538 - BMB-101 in Absence Epilepsy and DEE | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

September 15, 2025

Study Completion Date

November 30, 2025

Conditions

Absence EpilepsyJeavons SyndromeDravet SyndromeLennox Gastaut Syndrome

Interventions

DRUG

BMB-101

BMB-101 liquid administered orally twice a day for 3 months

Trial Locations (5)

RECRUITING

The Prince of Wales Hospital, Randwick

RECRUITING

Alfred Health, Melbourne

RECRUITING

St Vincent's Hospital Melbourne, Fitzroy

RECRUITING

Austin Health, Heidelberg

RECRUITING

Royal Brisbane and Womans Hospital, Herston